| GTO ID | GTC0474 |
| Trial ID | NCT03899415 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | HBV gene |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HBV TCR-T cells |
| HLA | HLA-A*02:01|HLA-CW*08:01 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | TCR-Redirected T Cells Therapy in Patient With HBV Related HCC |
| Year | 2019 |
| Country | China |
| Company sponsor | Beijing 302 Hospital |
| Other ID(s) | LTCR-HCC-3-1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||